ConductScience.org, home

Paper40323335

Modulation of the PI3K/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity.

Hedayati N and 11 others. Discov Oncol, 2025. Cited by 46 papers, by iCite.

Cite this record

ConductScience Library. Modulation of the PI3K/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity. Papers, record 40323335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40323335

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modulation of the PI3K/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity.
PubMed
Journal
Discov Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
46
iCite
Relative citation ratio, by iCite
14.9, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hedayati NNeda
2Safari MHMohamad Hosein
3Milasi YEYaser Eshaghi
4Kahkesh SSamaneh
5Farahani NNajma
6Khoshnazar SMSeyedeh Mahdieh
7Dorostgou ZZahra
8Alaei EElmira
9Alimohammadi MMina
10Rahimzadeh PPayman
11Taheriazam AAfshin
12Hashemi MMehrdad

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References209

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127779703Resveratrol induces cell cycle arrest and apoptosis in human eosinophils from asthmatic individuals.Mol Med Rep2016https://conductscience.org/library/papers/27779703PubMed
234052324Resveratrol for cancer therapy: Challenges and future perspectives.Cancer Lett2021https://conductscience.org/library/papers/34052324PubMed
321942447Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells.J Agric Food Chem2011https://conductscience.org/library/papers/21942447PubMed
425515619Resveratrol induces cell cycle arrest via a p53-independent pathway in A549 cells.Mol Med Rep2015https://conductscience.org/library/papers/25515619PubMed
536335870Resveratrol inhibits proliferation and induces apoptosis via the Hippo/YAP pathway in human colon cancer cells.Biochem Biophys Res Commun2022https://conductscience.org/library/papers/36335870PubMed
629027178Mechanisms of regulation of normal and metaplastic intestinal differentiation.Histol Histopathol2018https://conductscience.org/library/papers/29027178PubMed
732531316Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved.Arch Biochem Biophys2020https://conductscience.org/library/papers/32531316PubMed
830946868Targeting PI3K signaling in cancer: Challenges and advances.Biochim Biophys Acta Rev Cancer2019https://conductscience.org/library/papers/30946868PubMed
933187910Oncostatin M: A mysterious cytokine in cancers.Int Immunopharmacol2021https://conductscience.org/library/papers/33187910PubMed
1026530632Resveratrol induces cell cycle arrest in human gastric cancer MGC803 cells via the PTEN-regulated PI3K/Akt signaling pathway.Oncol Rep2016https://conductscience.org/library/papers/26530632PubMed
1124244343Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway.PLoS One2013https://conductscience.org/library/papers/24244343PubMed
1223464396Resveratrol affects protein kinase C activity and promotes apoptosis in human colon carcinoma cells.Asian Pac J Cancer Prev2012https://conductscience.org/library/papers/23464396PubMed
1328989978The therapeutic potential of resveratrol: a review of clinical trials.NPJ Precis Oncol2017https://conductscience.org/library/papers/28989978PubMed
1417988825Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells.Biomed Pharmacother2008https://conductscience.org/library/papers/17988825PubMed
1516039868Rapamycin: an anti-cancer immunosuppressant?Crit Rev Oncol Hematol2005https://conductscience.org/library/papers/16039868PubMed
1633937049Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors.Front Oncol2021https://conductscience.org/library/papers/33937049PubMed
1720036794Inflammation and oncogenesis: a vicious connection.Curr Opin Genet Dev2010https://conductscience.org/library/papers/20036794PubMed
1817112576Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.Cell2006https://conductscience.org/library/papers/17112576PubMed
1933292283Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer.Cancer Cell Int2020https://conductscience.org/library/papers/33292283PubMed
2035425710Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges.Front Oncol2022https://conductscience.org/library/papers/35425710PubMed

See all 209 referencesDownload CSV of references

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.

PMIDTitleJournalYearIn PapersSource
42819232Identification of natural TLR4 modulators through network pharmacology and molecular modeling in SARS-CoV-2 Acinetobacter baumannii co-infection.Front Chem2026https://conductscience.org/library/papers/42819232PubMed
42792182Phytochemicals and Irisin as Multi-Target Regulators of Adipose Tissue Browning and Metabolic Reprogramming: Synergies with GLP-1 Pathways.Antioxidants (Basel)2026https://conductscience.org/library/papers/42792182PubMed
42726166Dysregulation of the TLR4/MYD88 Signaling Pathway in Egyptian Females with Breast Cancer: Implications for Tumor Progression.Mol Biol Rep2026https://conductscience.org/library/papers/42726166PubMed
42643477A novel combinatorial therapeutic strategy using resveratrol and viral oncolysis for diffuse intrinsic pontine glioma: an in vitro study.3 Biotech2026https://conductscience.org/library/papers/42643477PubMed
42621019Neurogenesis and neuroplasticity activities of natural products: therapeutic potential in Alzheimer's disease.Front Pharmacol2026https://conductscience.org/library/papers/42621019PubMed
42588067Mechanistic Biological Insights into the Effects of Resveratrol and Nano-Resveratrol on EAT-Induced Hepatorenal Damage.Nutrients2026https://conductscience.org/library/papers/42588067PubMed
42588034Nutraceuticals in Uro-Oncology: A Structured Expert Review and Precision-Oriented Framework.Nutrients2026https://conductscience.org/library/papers/42588034PubMed
42573911Effect of Polyphenols Derived from Medicinal Plants on Multiple Myeloma via Modulating Bone Marrow Microenvironment.Chin J Integr Med2026https://conductscience.org/library/papers/42573911PubMed
42511744Oxyresveratrol Suppresses EGF-Induced AKT Phosphorylation and Reduces Cellular Fitness While Promoting Apoptosis in EGFR-Wild-Type Non-Small Cell Lung Cancer Cells Under EGF Stimulation.Int J Mol Sci2026https://conductscience.org/library/papers/42511744PubMed
42449984The Follicular Immune Checkpoint: PD-1/PD-L1 and Immune Tolerance in Oocyte Competence and IVF Failure.Int J Mol Sci2026https://conductscience.org/library/papers/42449984PubMed
42416332Impact of plant-based interventions on gynecological cancers: a narrative review of mechanistic interplays and clinical evidence.Front Mol Med2026https://conductscience.org/library/papers/42416332PubMed
42371247Epigenetic Regulations by Olive Bioactives: Targeting HDAC for Disease Prevention and Therapy.Curr Nutr Rep2026https://conductscience.org/library/papers/42371247PubMed
42358819Resveratrol in Oral Squamous Cell Carcinoma: Preclinical Evidence and Translational Opportunities.Oncol Res2026https://conductscience.org/library/papers/42358819PubMed
42196257Plant-Derived Bioactive Compounds and Their Therapeutic Potential in Cancer.Int J Mol Sci2026https://conductscience.org/library/papers/42196257PubMed
42193184Anti-Hepatocarcinoma Activity and Mechanism of Isosendanin and Its Novel Structural Analogues Isolated from the Bark of Melia azedarach L.: In Vitro and In Vivo Studies.Antioxidants (Basel)2026https://conductscience.org/library/papers/42193184PubMed
42147231Natural supplements in breast cancer therapy: translational evidence, clinical safety, and emerging challenges.Front Oncol2026https://conductscience.org/library/papers/42147231PubMed
42075806Bioactive Natural Compounds in Triple-Negative Breast Cancer: Molecular Targets and Therapeutic Perspectives.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42075806PubMed
42016224Arachis hypogaea L. Root Extract Mitigates Testosterone Propionate-Induced Benign Prostatic Hyperplasia in ICR Mice by Suppressing Inflammation, Androgen Receptors, and Dihydrotestosterone.Food Sci Nutr2026https://conductscience.org/library/papers/42016224PubMed
41994628
Advances in polyphenol-based strategies for musculoskeletal recovery and exercise rehabilitation in cancer: Mechanistic insights into Wnt/β-catenin and PI3K/Akt signaling pathways and inflammatory markers.
Front Oncol2026https://conductscience.org/library/papers/41994628PubMed
41888500Photobiomodulation at 830 nm with 5 J/cm2 does not promote PI3K/AKT/mTOR signalling pathway activation in hyperglycemic wounded cells.Lasers Med Sci2026https://conductscience.org/library/papers/41888500PubMed

See all 39 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
PIK3R15295PubTator's text mininghttps://conductscience.org/library/genes/5295NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40323335

GET https://conductscience.org/api/papers/v1/40323335/references?page=2